Beurs gesloten -
Nasdaq
22:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
397,5
USD
|
-0,06%
|
|
+0,81%
|
-2,31%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
56.303
|
61.457
|
55.834
|
74.127
|
104.849
|
102.732
|
-
|
-
|
Bedrijfswaarde
1 |
52.495
|
54.798
|
48.309
|
63.349
|
93.630
|
85.818
|
81.450
|
77.391
|
K/w-verhouding
|
48,5
x
|
23
x
|
24,4
x
|
22,5
x
|
29,3
x
|
26,7
x
|
23,2
x
|
20,9
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
13,5
x
|
9,9
x
|
7,37
x
|
8,3
x
|
10,6
x
|
9,58
x
|
8,75
x
|
7,96
x
|
Bedrijfswaarde/omzet
|
12,6
x
|
8,83
x
|
6,38
x
|
7,09
x
|
9,49
x
|
8
x
|
6,94
x
|
6
x
|
Bedrijfswaarde/EBITDA
|
27,7
x
|
15,2
x
|
10,8
x
|
12,8
x
|
20,6
x
|
16,2
x
|
14,1
x
|
12,3
x
|
Bedrijfswaarde/FCF
|
35,1
x
|
18,3
x
|
20,1
x
|
16,1
x
|
28,1
x
|
19,8
x
|
17,5
x
|
14,4
x
|
FCF Yield
|
2,85%
|
5,46%
|
4,99%
|
6,2%
|
3,56%
|
5,06%
|
5,7%
|
6,96%
|
Price to Book
|
9,38
x
|
7,07
x
|
5,53
x
|
5,33
x
|
5,96
x
|
5,01
x
|
4,32
x
|
4,04
x
|
Aantal aandelen (in duizenden)
|
257.150
|
260.038
|
254.252
|
256.691
|
257.683
|
258.459
|
-
|
-
|
Referentieprijs
2 |
219,0
|
236,3
|
219,6
|
288,8
|
406,9
|
397,5
|
397,5
|
397,5
|
Datum van publicatie
|
30-01-20
|
01-02-21
|
26-01-22
|
07-02-23
|
05-02-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
4.163
|
6.206
|
7.574
|
8.931
|
9.869
|
10.723
|
11.744
|
12.906
|
EBITDA
1 |
1.893
|
3.601
|
4.470
|
4.941
|
4.556
|
5.298
|
5.774
|
6.271
|
Bedrijfsresultaat (EBIT)
1 |
1.786
|
3.491
|
4.344
|
4.793
|
4.375
|
4.971
|
5.453
|
6.057
|
Operationele Marge
|
42,9%
|
56,25%
|
57,35%
|
53,67%
|
44,33%
|
46,35%
|
46,43%
|
46,93%
|
Resultaat voor belastingen (EBT)
1 |
1.395
|
3.117
|
2.730
|
4.232
|
4.380
|
4.838
|
5.608
|
6.423
|
Nettowinst (verlies)
1 |
1.177
|
2.712
|
2.342
|
3.322
|
3.620
|
3.857
|
4.445
|
5.097
|
Nettomarge
|
28,27%
|
43,7%
|
30,92%
|
37,2%
|
36,68%
|
35,97%
|
37,85%
|
39,49%
|
WPA
2 |
4,510
|
10,29
|
9,010
|
12,82
|
13,89
|
14,90
|
17,11
|
19,01
|
Free Cash Flow
1 |
1.494
|
2.994
|
2.408
|
3.925
|
3.337
|
4.344
|
4.642
|
5.387
|
FCF-marge
|
35,89%
|
48,24%
|
31,8%
|
43,95%
|
33,81%
|
40,51%
|
39,53%
|
41,74%
|
Kasstroomconversie (ebitda)
|
78,92%
|
83,15%
|
53,89%
|
79,44%
|
73,24%
|
82%
|
80,4%
|
85,9%
|
Kasstroomconversie (nettowinst)
|
126,94%
|
110,4%
|
102,84%
|
118,16%
|
92,19%
|
112,62%
|
104,43%
|
105,69%
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
30-01-20
|
01-02-21
|
26-01-22
|
07-02-23
|
05-02-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Omzet
1 |
1.984
|
2.073
|
2.098
|
2.196
|
2.334
|
2.303
|
2.375
|
2.493
|
2.484
|
2.518
|
2.579
|
2.652
|
2.709
|
2.778
|
2.691
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1.215
|
1.210
|
1.256
|
1.277
|
1.284
|
1.250
|
-
|
Bedrijfsresultaat (EBIT)
1 |
1.188
|
1.124
|
1.166
|
1.187
|
1.289
|
1.150
|
902,3
|
1.148
|
1.173
|
1.151
|
1.201
|
1.224
|
1.240
|
1.270
|
1.326
|
Operationele Marge
|
59,89%
|
54,23%
|
55,61%
|
54,05%
|
55,24%
|
49,95%
|
37,99%
|
46,04%
|
47,24%
|
45,73%
|
46,57%
|
46,15%
|
45,76%
|
45,73%
|
49,3%
|
Resultaat voor belastingen (EBT)
1 |
1.083
|
870,9
|
954,8
|
1.024
|
1.176
|
1.077
|
891,5
|
1.162
|
1.179
|
1.148
|
1.185
|
1.203
|
1.223
|
1.229
|
1.286
|
Nettowinst (verlies)
1 |
851,9
|
770,1
|
762,1
|
810,5
|
930,5
|
818,9
|
699,8
|
915,7
|
1.035
|
968,8
|
946,6
|
960
|
970,7
|
960,6
|
1.016
|
Nettomarge
|
42,94%
|
37,16%
|
36,33%
|
36,9%
|
39,86%
|
35,56%
|
29,47%
|
36,73%
|
41,69%
|
38,48%
|
36,7%
|
36,2%
|
35,83%
|
34,58%
|
37,76%
|
WPA
2 |
3,280
|
3,000
|
2,960
|
3,130
|
3,590
|
3,150
|
2,690
|
3,520
|
3,970
|
3,710
|
3,680
|
3,720
|
3,774
|
3,801
|
3,850
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
02-11-21
|
26-01-22
|
05-05-22
|
04-08-22
|
27-10-22
|
07-02-23
|
01-05-23
|
01-08-23
|
06-11-23
|
05-02-24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
3.808
|
6.659
|
7.525
|
10.779
|
11.218
|
16.914
|
21.283
|
25.342
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
1.494
|
2.994
|
2.409
|
3.925
|
3.337
|
4.344
|
4.642
|
5.387
|
ROE (netto-inkomsten/eigen vermogen)
|
22,4%
|
36,7%
|
36%
|
32,1%
|
23%
|
22,7%
|
21,1%
|
22,7%
|
ROA (netto-inkomsten/totale activa)
|
16,2%
|
27%
|
18,8%
|
21%
|
17,7%
|
15,1%
|
13,6%
|
12,9%
|
Totale activa
1 |
7.282
|
10.035
|
12.433
|
15.792
|
20.441
|
25.503
|
32.795
|
39.453
|
Nettoactief per aandeel
2 |
23,30
|
33,40
|
39,70
|
54,10
|
68,20
|
79,30
|
92,00
|
98,50
|
Cashflow per aandeel
2 |
6,020
|
12,40
|
10,20
|
15,90
|
13,60
|
19,30
|
19,90
|
20,30
|
Capex
1 |
75,5
|
260
|
235
|
205
|
200
|
216
|
224
|
238
|
Capex/omzet
|
1,81%
|
4,19%
|
3,1%
|
2,29%
|
2,03%
|
2,01%
|
1,91%
|
1,85%
|
Datum van publicatie
|
30-01-20
|
01-02-21
|
26-01-22
|
07-02-23
|
05-02-24
|
-
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
397,5
USD Gemiddelde koersdoel
459,7
USD Spread / Gemiddelde doel +15,66% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -2,31% | 103 mld. | | +0,56% | 95,28 mld. | | +1,69% | 22,15 mld. | | -17,37% | 21,02 mld. | | -9,30% | 18,15 mld. | | -41,01% | 16,74 mld. | | -14,85% | 16,05 mld. | | +3,21% | 13,68 mld. | | +33,54% | 12,17 mld. | | -24,71% | 8,24 mld. |
Biotherapeutische geneesmiddelen
|